|
| Issue Date | Title | Author(s) |
| Aug-2019 | 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation | Sobhy, Mahitab K; Mowafy, Samar; Lasheen, Deena S. ; Farag, Nahla A; Khaled A M Abouzid |
| 5-Feb-2024 | Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma | Khodair, Ahmed I; Cagle-White, Brittnee; Abdel Aziz, May H; Hanafy, Mahmoud Kh; Mowafy, Samar; Prof. Hamdy, Nadia M. ; Kassab, Shaymaa E; El-Hallouty, Salwa M. |
| Mar-2013 | Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors | Mowafy, Samar; Farag, Nahla A; Abouzid, Khaled |
| Dec-2021 | Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer | Abdel-Atty, Mona M; Farag, Nahla A; Serya, Rabah A T; Abouzid, Khaled ; Mowafy, Samar |
| 15-Aug-2016 | Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives | Mowafy, Samar; Galanis, A; Doctor, Zainab M; Paranal, Raymond M; Lasheen, Deena S. ; Farag, Nahla A; Jänne, Pasi A; Abouzid, Khaled |
